Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
73 /100
HIGH RISK
Score updated Aug 28, 2026

COCP — Cocrystal Pharma, Inc. Dilution Risk Tracker

Track COCP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track COCP — Get alerts when the score changes →

As of August 28, 2026, Cocrystal Pharma, Inc. (COCP) has a DilutionWatch DilutionScore of 73/100, rated HIGH dilution risk. Cocrystal Pharma, Inc. has a market capitalization of $15.44M, 19.26M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $150.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
96
💰 Cash Runway
65
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 32%
🔄 Reverse Split model est. 40%
• 50-day avg $1.29 approaching $1 threshold
• 8 months cash with weak price
💰 Capital Raise model 35%
• Under 12 months cash (8mo)
• Active shelf registration ($150M, 971% of market cap)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (73/100)
🔔 Track COCP — Get forecast alerts →

Market Data

Market Cap$15.44M
Shares Outstanding19.26M
Float9.12M
Cash$8.02M
Debt$50.10M
Short InterestN/A

Institutional Holdings

10 institutional holders · 712.5K shares
#1 Vanguard Group Inc 264.0K shares
#2 Renaissance Technologies, LLC 126.0K shares
#3 Geode Capital Management, LLC 82.5K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest388.0K
Days to Cover14.2
% of Float4.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2024-12-31
xbrl XBRL CONVERTIBLE 2018-12-31
EFFECT EFFECT 2026-05-01
S-3 SHELF 2026-04-23
4 INSIDER TRANSACTION 2026-02-25
Full SEC filing analysis available with free account

Recent News

No recent news

Factual COCP Dilution Snapshot

Cocrystal Pharma, Inc. (COCP) has a DilutionScore of 73/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track COCP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking COCP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for COCP
COCP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.